TMJ surgery precertification review required

All TMJ surgical precertification requests or claims are reviewed by Aetna's Oral and Maxillofacial Surgery (OMS) Patient Management Unit; submit a problem-specific history (Aetna TMJ Questionnaire), physical exam, TMJ imaging reports, records documenting 3–6 months of non-surgical management (nature, results, and findings), and the proposed treatment plan for review.

• Include Aetna Temporomandibular Disorder Questionnaire and problem-specific history
• Provide TMJ radiographs/diagnostic imaging reports and physical examination findings
• Document 3–6 months of non-surgical management with results and the proposed surgical plan

Imaging covered only if tied to anticipated surgery

Certain imaging studies (e.g., CT, MRI, specified TMJ radiographs) are considered medically necessary only when used in conjunction with anticipated surgical management; when submitting imaging, link the study to planned surgery or surgical evaluation.

• CT or MRI: only when used in conjunction with anticipated surgical management
• Specific codes (e.g., 70328, 70486, 70487, 70488) are covered only with anticipated surgical management

Prior authorization for total TMJ replacement — document indication and prior treatments

Requests for total TMJ replacement must document FDA‑approved indication and prior unsuccessful conservative and surgical treatments; provide imaging demonstrating the device‑level criteria (e.g., loss of smooth fossa, damaged condyles, recurrent ankylosis) and prior treatment history.

• Document prior conservative management and other surgical attempts
• Include imaging showing one or more device indication findings (e.g., non–ball-shaped condyles, loss of articular fossa)

Irreversible mandibular repositioning — strong justification required

Irreversible mandibular repositioning procedures (equilibration, orthodontics, full‑mouth reconstruction, orthognathic surgery) are generally not considered medically necessary for most TMDs and will require strong, case-specific justification if prior authorization is sought.

• Provide clear documentation of conservative‑treatment failure and specific medical necessity if requesting authorization
• Anticipate high risk for denial when irreversible repositioning is proposed without robust justification

PA recommended for intra‑articular biologics and adjuncts (PRGF/PRP/HA)

Prior authorization is recommended for intra‑articular biologic or adjunctive injections (PRGF/PRP, hyaluronic acid, other intra‑articular biologics) because evidence is inconsistent; include prior conservative care and rationale when requesting coverage.

• Include prior conservative treatment attempts and results
• Provide trial-level evidence or rationale supporting off‑label/adjunctive IA biologic use

No explicit prior authorization code requirements in this section

This background section summarizes diagnostic and procedural evidence (ultrasound guidance, CT confirmation, imaging sensitivity/specificity) but does not specify explicit prior authorization code requirements or instructions.

• Use the documented imaging and technique evidence to support clinical submissions, but do not expect code‑level PA rules here

Document imaging guidance and confirmation for image‑guided TMJ injections/surgery

When planning image‑guided intra‑articular injections or TMJ surgery, document the imaging guidance modality (e.g., ultrasound), CT confirmation if used, laterality/number of injections, and accuracy of needle placement to support the procedure.

• Record imaging guidance modality (US, CT) and whether CT confirmation was performed
• Document needle placement accuracy (CT‑confirmed intra‑articular placement rates) and sterile technique

PA recommended for experimental biologic IA injections (e.g., BMAC)

Emerging intra‑articular biologic procedures (for example, BMAC for TMJ osteoarthritis) are preliminary; obtain prior authorization and submit supporting trial data, rationale, and outcomes when requesting coverage.

• Provide the small‑trial data, follow‑up intervals, and justification for use in the individual patient
• Anticipate investigational review and potential denial without strong supporting evidence

No specific prior authorization code instructions in this portion

This portion of the policy provides background evidence and does not list specific prior authorization codes, numeric PA rules, or code‑level submission instructions.

• Refer to other sections for code lists and PA procedures; no new code requirements are stated here

Surgery only after failure of comprehensive non‑surgical management (≥3 months)

Surgery is considered only after documented failure of comprehensive non‑surgical management — include documentation of at least 3 months (typically 3–6 months) of professional physical therapy, pharmacologic therapy, behavioral therapy, manipulation (if indicated), and reversible intra‑oral appliances where appropriate.

• Document nature and results of non‑surgical treatments over 3–6 months
• Confirm that surgery is being considered only after these measures have been exhausted except in urgent cases (e.g., bony ankylosis)

Document conservative therapies and trials before surgery

Non‑surgical conservative therapies (occlusal appliance therapy, physical therapy, medical management, behavioral therapy) should be tried and documented prior to consideration of surgical interventions.

• Document occlusal appliance use, physical therapy courses, medications, and behavioral therapy sessions and outcomes
• Appliance therapy trials for intracapsular problems should be provided for at least 2–3 months when tolerated

Conservative‑first approach — document manual therapy and therapeutic exercise

Conservative, low‑cost, reversible therapies such as manual therapy, therapeutic exercise, and related non‑invasive modalities are primary management options and should be documented as tried prior to invasive or irreversible procedures.

• Record dates, frequency, and response to manual therapy, therapeutic exercise, and counseling
• Include objective outcome measures (pain VAS, MMO/MMI) when available

Consider arthrocentesis as first invasive step; document response before adjuncts

Given consistent evidence that arthrocentesis alone reduces pain and improves jaw function and that adjunctive intra‑articular supplements have not consistently improved outcomes, clinicians should consider arthrocentesis before adding intra‑articular supplements and document the rationale.

• Document indication for arthrocentesis and clinical response before pursuing adjunctive IA injections
• If adjunctive IA agents are used, include justification and prior arthrocentesis outcomes

No formal step‑therapy rules specified

No formal step‑therapy program is prescribed in the policy; evidence summaries note arthrocentesis alone often provided benefit and that adjunctive IA supplements did not consistently add durable improvement.

• Although no mandated step‑therapy algorithm exists, document prior treatments and responses when requesting advanced therapies
• Use evidence summaries to support clinical decision‑making rather than relying on a formal step protocol

Document trials of conservative therapy before invasive procedures

Evidence supports conservative first‑line treatments (NSAIDs, non‑biologic DMARDs where applicable, counseling, manual/physical therapy, splints) prior to more invasive procedures; document trials, duration, and outcomes.

• Record medication trials (agents, doses, duration) and response
• Include objective outcome measures and timeframes (e.g., 1, 3, 6 months) when available

Conservative combination therapies should be documented prior to escalation

Combination conservative therapies (counseling, manual therapy, physical therapy, splint therapy) have small effect sizes but are supported as initial care; document use of combination approaches before escalating to invasive or experimental treatments.

• Provide records of combined conservative modalities and objective measures of improvement or lack thereof
• Note duration and adherence to combination therapy when included in surgical review

No step‑therapy mandates in these excerpts — still document prior care

There are no formal step‑therapy mandates in the cited sections; however, document prior non‑surgical care and responses when submitting requests for advanced or experimental treatments.

• Include clear chronology of prior therapies and objective outcomes when seeking authorization for non‑standard procedures

Submit Aetna TMJ Questionnaire, exam, imaging, and 3–6 months non‑surgical therapy documentation

Submit the Aetna Temporomandibular Disorder Questionnaire, a focused physical exam, TMJ imaging reports, and records documenting 3–6 months of non‑surgical therapy (nature, results, and findings) along with the proposed treatment plan for surgical reviews.

• Attach completed Aetna TMJ Questionnaire and problem‑specific history
• Provide detailed documentation of non‑surgical therapy trials, including dates, providers, interventions, and outcomes

Imaging codes covered only with anticipated surgical management — document linkage

Certain imaging CPT codes (e.g., 70328, 70330, 70336, 70355, 70486, 70487, 70488, 70540–70543) are covered only when performed in conjunction with anticipated surgical management; when billing these codes, include documentation linking the imaging to planned surgery.

• When submitting claims for these imaging codes, include the surgical plan or indication for operative management
• If imaging is for initial evaluation without surgical intent, these codes may not be considered medically necessary

Use and document appropriate procedure/HCPCS/CPT/Dental and ICD‑10 codes

Bill using the appropriate procedure and HCPCS/CPT/dental codes listed in the policy and include relevant ICD‑10 diagnosis codes (e.g., M26.601–M26.69) when selection criteria are met; ensure coding matches documented indication and imaging.

• Use covered CPT/HCPCS/D codes from the policy when submission aligns with medical necessity criteria
• Include ICD‑10 diagnosis codes for TMJ disorders when selection criteria are satisfied

Documentation expectations for orthodontic TMD interventions — ≥2 baseline signs/symptoms

Orthodontic TMD intervention studies require clear diagnostic criteria and documentation of at least two signs or symptoms of TMD at baseline; when submitting orthodontic interventions for TMD, include baseline signs/symptoms and trial details.

• Document at least two baseline TMD signs/symptoms and exclude splint‑only or prior surgical cases if applicable
• Include study‑like criteria if relying on orthodontic intervention evidence

Suggested documentation for IA biologic/adjunct requests (include prior operative details and outcomes)

When requesting intra‑articular biologic or adjunctive injections (PRGF/PRP/HA/other biologics), include prior operative details (arthroscopy/arthrocentesis), randomized trial‑level justification if available, baseline pain and mandibular opening measurements, imaging findings, prior conservative therapy attempts, and rationale for off‑label or adjunctive use.

• Provide prior operative reports (arthroscopy/arthrocentesis) and outcomes
• Include baseline and follow-up outcome measures (pain VAS, MMO/MMI) and relevant trial evidence

Document imaging guidance modality and CT confirmation for image‑guided injections

Document the imaging guidance modality (e.g., ultrasound) and any CT confirmation used for image‑guided TMJ injections, and specify laterality and number of injections to support accuracy and appropriateness.

• Record use of US guidance and whether CT confirmation was performed
• Indicate laterality, number of injections, agent and dose when applicable

Required procedural and outcomes documentation for IA TMJ injections

For intra‑articular TMJ injections, record the indication (e.g., JIA with MRI evidence of TMJ inflammation), imaging guidance used (US, CT), agent and dose (e.g., triamcinolone hexacetonide/acetonide), and pre/post outcome measures (pain, maximal incisal opening, MRI findings); lack of these procedural and outcomes data may risk denial.

• Include agent name and dose, imaging guidance, and objective pre/post measures (pain VAS, MIO/MMO)
• Attach MRI findings when used to justify indication (e.g., JIA inflammation)

Document trial design and outcomes when relying on evidence for biologics or BMAC

When relying on clinical evidence to justify manual therapy, IA biologics (PRP/PRF), or BMAC, document trial design, outcomes, follow‑up intervals (e.g., 1, 3, 6, 12, 18 months), and specific outcome measures (pain VAS, MMO) from cited RCTs or studies to support medical necessity.

• Provide cited trial details (design, sample size, follow‑up) and link trial outcomes to the patient’s clinical course
• Include objective measures and timepoints used in the supporting studies

Administrative/contact info — no new clinical documentation requirements

Administrative and contact information is provided in this policy; this section does not add additional clinical documentation requirements beyond those specified elsewhere in the bulletin.

• Use the contact and administrative references in the policy for submission queries
• Follow the documentation lists in the surgical and procedural sections for clinical requirements

Provide complete problem‑specific documentation for OMS surgical review

Requests for TMJ surgery undergo OMS patient management unit review and must include problem‑specific history, exam, imaging, documentation of 3–6 months of non‑surgical management, and the proposed surgical plan; failure to provide these items may delay or result in denial.

• Attach Aetna TMJ Questionnaire and detailed non‑surgical treatment chronology
• Provide imaging and explicit surgical rationale tied to failed conservative care

Some CPT codes not covered for specified indications — check policy lists

Certain CPT codes are listed as not covered for specified indications in the policy (for example, arthrocentesis for viscosupplementation injection and some intra‑articular injection indications); follow the policy code exclusions to avoid claim denials.

• Do not bill covered benefits for indications explicitly listed as not covered (e.g., viscosupplementation via arthrocentesis)
• Review the policy’s CPT/HCPCS lists before submission

Certain CPT/HCPCS/Dental codes are not covered for listed indications

Specific CPT/HCPCS/dental codes (e.g., 0232T, 0481T and multiple dental/prosthodontic codes) are identified as not covered for indications listed in the CPB; do not submit claims for these codes for excluded indications.

• Verify that the billed code is not among those listed as not covered for the requested indication
• If using an investigational/experimental procedure, expect prior authorization denial without compelling supporting evidence

Specialized radiology not necessary unless surgery planned — document surgical intent

Specialized radiological studies (e.g., cephalometric x‑rays, tomograms) are not medically necessary for evaluating TMD unless surgery is being considered; if performed for surgical planning, document the surgical intent.

• When ordering specialized radiology, include statement linking imaging to anticipated surgery
• Routine use of these studies for non‑surgical evaluation may not be supported

High denial risk for irreversible mandibular repositioning procedures

Irreversible mandibular repositioning procedures are argued not medically necessary for most TMDs and are at high risk for denial when not supported by documented conservative‑treatment failure and compelling medical necessity.

• Provide exhaustive prior conservative treatment documentation if requesting authorization
• Anticipate denials if the procedure is irreversible and lacks strong, case‑specific justification

Potential denial triggers when evidence of durable benefit is limited

Interventions lacking clear or durable benefit in cited studies (for example, PRGF showing no added improvement at 2 years; inconsistent benefits of adjunctive IA supplements) may trigger medical necessity review or denial if submitted without strong supporting clinical justification.

• Include long‑term outcome data and justification when requesting coverage for adjunctive IA agents
• Be prepared for investigational review for biologics with limited or mixed evidence

Document image‑guided injection accuracy and confirmation

Ultrasound guidance with CT confirmation achieved high intra‑articular needle placement accuracy in cited cohorts; document image‑guided technique and confirmation to support claims of accurate intra‑articular delivery.

• Report whether CT confirmation was used and CT‑confirmed intra‑articular placement rates if available
• Document sterile technique and any complications

Image‑guided injection documentation required — accuracy and sterile technique

For image‑guided TMJ injections, document needle placement accuracy, use of sterile technique, imaging guidance modality, and any complications; failure to document technique or outcomes may prompt medical necessity review or denial.

• Include CT confirmation or other imaging evidence of intra‑articular placement when available
• Record procedural details (needle approach, guidance used, agent/dose, sterile field) in the operative note

Telemedicine documentation risk — remote assessment may be insufficient for complex TMD

Telemedicine evaluations lack a physical examination component and may be insufficient for complex or severe TMD cases; claims relying solely on remote assessment could be at risk for denial if documentation does not justify remote‑only management.

• When using telemedicine for TMD management, document why in‑person exam was not necessary or feasible
• Provide supplemental objective data (imaging, prior in‑person exams) to support management decisions

No explicit authorization/denial criteria in this policy history section

This background/policy history portion does not specify explicit authorization or denial criteria; refer to the policy’s clinical sections for actionable prior authorization and documentation requirements.

• Use the clinical criteria and documentation sections to prepare submissions; policy history contains administrative details